Homer, N., Grewal, D. S., Mirza, R. G., Lyon, A. T., & Gill, M. K. (2015). Response to: ‘Comment on Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results'. Eye (Lond).
Styl ChicagoHomer, N., D S. Grewal, R G. Mirza, A T. Lyon, a M K. Gill. "Response To: ‘Comment On Transitioning to Intravitreal Aflibercept Following a Previous Treat-and-extend Dosing Regimen in Neovascular Age-related Macular Degeneration: 24-month Results'." Eye (Lond) 2015.
Citace podle MLAHomer, N., et al. "Response To: ‘Comment On Transitioning to Intravitreal Aflibercept Following a Previous Treat-and-extend Dosing Regimen in Neovascular Age-related Macular Degeneration: 24-month Results'." Eye (Lond) 2015.